Newly arrived migrant
BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.
Adult
Laboratory tests
- FBC with blood film
- Serum creatinine
- AST
- ALT
- Fasting plasma glucose (or capillary glucose)if neededAged 45 or over; 35 or over if origin from the Indian subcontinent, Middle East or Africa, family history of diabetes, history of gestational diabetes, cardiovascular risk factor or overweight.
- Urine dipstick
- HIV serology
- Hepatitis B serology (HBsAg, anti-HBs antibodies, anti-HBc antibodies)
- Hepatitis C serology
- Syphilis serology
- Chlamydia trachomatis and Neisseria gonorrhoeae NAAT (PCR) (on urine, vaginal, anal and/or pharyngeal sample)if neededSexually active person aged 25 or under, or sexual behaviour exposing to STIs (unprotected intercourse with casual partners, multiple partners, MSM, sex work, precariousness exposing to sexual vulnerability even if not verbalised). Sites according to sex and practices.
- hCGif neededWoman of childbearing potential with a possible pregnancy (late period, mention of pregnancy) on history.
- Lipid profileif neededMan aged 40 or over, woman aged 50 or over, cardiovascular risk factor, or woman before hormonal contraception.
- hepatitis A serology (IgG)if neededMan who has sex with men, with a view to catch-up vaccination against hepatitis A (the page’s note adds plans to travel to an endemic area).
- strongyloidiasis serology (strongyloidosis)if neededOrigin from a strongyloidiasis-endemic area: Central and South America, Caribbean, Africa, Central, South and South-East Asia, Indonesia, Eastern Europe. Routine in this case.
- varicella serologyif neededPerson aged 12 to 40 with no history of chickenpox on history, to vaccinate if serology is negative.
- bilharziasis serologyif neededOrigin from sub-Saharan Africa or Egypt (routine in this case).
- filariasis serologyif neededOrigin from the forested areas of Central Africa (Angola, Cameroon, Gabon, Equatorial Guinea, Nigeria, Congo, Central African Republic, DRC, South Sudan, Chad). May be waived if the stay was exclusively urban.
- search for daytime microfilaraemiaif neededSame people as for filariasis serology (forested areas of Central Africa), with a daytime sample. Often not accessible in primary care: serology alone is then enough.
- HTLV-1 serologyif neededWoman of childbearing potential from sub-Saharan Africa, Latin America, the Caribbean or Japan.
- Chagas disease serologyif neededWoman of childbearing potential from South America, or whose mother is from there. Sometimes outside the fee schedule in primary care.
- haemoglobin electrophoresisif neededPlan to become parents or pregnancy (before 12 weeks of gestation) in a person from sub-Saharan Africa, North Africa, the Middle East, the Indian subcontinent, South-East Asia, intertropical Latin America or the Caribbean; or microcytosis on FBC.
- stool parasitology over 3 daysif neededOrigin from an endemic area (Central and South America, Caribbean, Africa, Central, South and South-East Asia, Indonesia), if the person agrees: 3 samples collected a few days apart.
- 24-hour urine parasitology (or failing that, on a complete morning void sample)if neededOrigin from sub-Saharan Africa only (testing for urinary schistosomiasis), if the person agrees.
- tetanus antibodies 4-8 weeks after the dTPca boosterif neededVaccination status unknown: check 4 to 8 weeks after a first dTcaP booster.
- anti-HBs antibodies 4-8 weeks after the hepatitis B boosterif neededVaccination status unknown with entirely negative hepatitis B serology: check 4 to 8 weeks after a first dose of hepatitis B vaccine.
- IGRA (interferon-gamma release assay) or tuberculin skin testif neededAdult aged 18 to 40 from a country where the incidence of tuberculosis exceeds 100/100 000, with or likely to have young children around them, or working in health care or early childhood, or immunocompromised.
Child
Laboratory tests
- FBC with blood film
- Serum creatinine
- AST
- ALT
- Urine dipstick
- Blood leadif neededChild under 16 years, in particular from a country with a high prevalence of lead poisoning (map on leadpollution.org); attach the Cerfa form.
- TSHif neededChild aged 1 month to 2 years (routine); after 2 years, only if there is a clinical pointer (TSH and T4). Before 1 month: Guthrie test.
- Serum ferritinif neededFerritin in every child aged 5 or under, and after 5 if risk factor (undernutrition, pubertal adolescent girl, haemoglobinopathy). CRP only if fever or suspected infection.
- CRPif neededFerritin in every child aged 5 or under, and after 5 if risk factor (undernutrition, pubertal adolescent girl, haemoglobinopathy). CRP only if fever or suspected infection.
- Serum albuminif neededProteinuria on dipstick (with urine protein:creatinine ratio and serum creatinine), or clinical undernutrition justifying a wider nutritional work-up.
- Haemoglobin electrophoresisif neededChild from sub-Saharan Africa, North Africa, the Middle East, South-East Asia, intertropical Latin America or the Caribbean. May be deferred after correction of iron deficiency.
- G6PD assayif neededHistory of haemolysis or jaundice, family cases, work-up before a treatment at risk of haemolysis, or other identified red cell disease.
- HIV serologyRecommended for every newly arrived migrant child, whatever the region of origin (same criteria as for adults: for everyone).
- Hepatitis B serology (HBsAg, anti-HBs antibodies, anti-HBc antibodies)Recommended for every newly arrived migrant child, whatever the region of origin (same criteria as for adults: for everyone).
- Hepatitis C serologyRecommended for every newly arrived migrant child, whatever the region of origin (same criteria as for adults: for everyone).
- Syphilis serologyif neededMinor sexually exposed (unaccompanied minors are included automatically), or risk of congenital syphilis in the infant (unmonitored pregnancy, clinical signs).
- Chlamydia trachomatis and Neisseria gonorrhoeae NAAT (PCR) (on urine, vaginal, anal and/or pharyngeal sample)if neededAdolescent and/or suspected sexual exposure; unaccompanied minors are considered exposed.
- hCGif neededAdolescent girl at risk of pregnancy (doubt on history).
- hepatitis A serology (IgG)if neededChild aged 1 to 18 likely to stay again in an endemic area, with a view to catch-up vaccination against hepatitis A.
- strongyloidiasis serology (strongyloidosis)if neededChild who learned to walk in a strongyloidiasis-endemic area (Central and South America, Caribbean, Africa, Central, South and South-East Asia, Indonesia, Eastern Europe).
- varicella serologyif neededAdolescent aged 12 or over with no history of chickenpox, to vaccinate if serology is negative.
- bilharziasis serologyif neededChild from sub-Saharan Africa or Egypt (same criteria as for adults).
- filariasis serologyif neededChild from the forested areas of Central Africa (Angola, Cameroon, Gabon, Equatorial Guinea, Nigeria, Congo, Central African Republic, DRC, South Sudan, Chad), unless the stay was exclusively urban.
- search for daytime microfilaraemiaif neededSame children as for filariasis serology (forested Central Africa), before any ivermectin treatment. If not accessible in primary care, serology alone is enough.
- HTLV-1 serologyif neededAdolescent girl of childbearing age from sub-Saharan Africa, Latin America, the Caribbean or Japan.
- Chagas disease serologyif neededAdolescent girl of childbearing age from South America, or whose mother is from there.
- stool parasitology over 3 daysif neededIn children, only if there are clinical or laboratory signs of deficiency or malnutrition.
- 24-hour urine parasitology (or failing that, on a complete morning void sample)if neededChild from sub-Saharan Africa (or Egypt according to table 2), especially if schistosomiasis serology is positive or if collection is easy.
- IGRA (in vitro interferon-gamma release assay) or tuberculin skin testif neededChild aged 18 or under from a country where the incidence of tuberculosis exceeds 40/100 000 and arrived in France less than 5 years ago (chest X-ray only if the test is positive or symptoms). IGRA reimbursed before age 15; from 15 to 18, CLAT (TB control centre, free of charge) or tuberculin skin test (IDR).
Do not order
- Routine stool parasitology in an asymptomatic child: not recommended (limited feasibility); reserve for clinical or laboratory warning signs [2].
- Chest X-ray straight away in a child: only if IGRA or tuberculin skin test is positive, or symptoms suggestive of tuberculosis (in adults, by contrast, it is indicated straight away if the country’s incidence exceeds 40/100 000) [2].
Sources (9)
- Eurostat. First permits issued for family reasons, education reasons, remunerated activities reasons, and other reasons by reason, length of validity and citizenship (migr_resfirst), France, 2022-2024. Données extraites par l'interface de diffusion d'Eurostat, consulté le 24/10/2026 (mise à jour des données du 22/10/2026).
- SPILF, SFP, SFLS. Bilan de santé à réaliser chez toute personne migrante primo-arrivante (adulte et enfant). Recommandation, juin 2024.
- European Centre for Disease Prevention and Control. Public health guidance on screening and vaccination for infectious diseases in newly arrived migrants within the EU/EEA. Stockholm : ECDC, décembre 2018.
- Office for Health Improvement and Disparities, UK Health Security Agency. Migrant health guide (gov.uk) : pages « Assessing new patients from overseas » (mise à jour du 2 août 2021), « HIV » (31 mars 2025), « Hepatitis B » et « Hepatitis C » (8 avril 2026), « Helminth infections » (31 mars 2025), « Tuberculosis (TB) » (31 mars 2025), « Non-infectious environmental hazards » (31 mars 2025).
- US Preventive Services Task Force. Human Immunodeficiency Virus (HIV) Infection: Screening. Final Recommendation Statement, 11 juin 2019 (grade A).
- US Preventive Services Task Force. Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2020;323(10):970-975.
- US Preventive Services Task Force. Hepatitis B Virus Infection in Adolescents and Adults: Screening. Final Recommendation Statement, 15 décembre 2020 (grade B).
- US Preventive Services Task Force. Latent Tuberculosis Infection in Adults: Screening. Final Recommendation Statement, 2 mai 2023 (grade B).
- National Institute for Health and Care Excellence. Tuberculosis. NICE guideline NG33, publiée le 13 janvier 2016, dernière mise à jour le 16 février 2024.